Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2013 by Vanderbilt-Ingram Cancer Center
Sponsor:
Collaborators:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
Mark Kelley, MD, Vanderbilt-Ingram Cancer Center
ClinicalTrials.gov Identifier:
NCT01701037
First received: September 21, 2012
Last updated: March 29, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)